MEDP INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff…
newsfilecorp.com

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
1 signal unavailable — limited data for this stock
Trend
+0.0% vs SMA 50 · +14.3% vs SMA 200
Momentum
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $6.3B $6.3B–$6.3B | — | $0.21 | — | — | Low1 |
FY2024 | $8.1B $8.1B–$8.1B | ▲ +29.2% | $3.08 | ▲ +1397.9% | — | Low1 |
FY2025 | $17.3B $17.3B–$17.3B | ▲ +112.8% | $5.92 | ▲ +92.3% | — | Low1 |
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff…

No description available.